Video

Dr Andrew Rhinehart: Improving Intermediate Outcomes in Diabetes Research

Andrew Rhinehart, MD, chief medical officer at Glytec, discusses the transition from intermediate outcomes in diabetes research of glycemic results to harder outcomes that will benefit the patient financially and through their care.

Andrew Rhinehart, MD, chief medical officer at Glytec, discusses the transition from intermediate outcomes in diabetes research of glycemic results to harder outcomes that will benefit the patient financially and through their care.

Transcript (slightly modified)

Can you describe the transition in diabetes research from focusing on glycemic results to costs for health systems?

Over the last year or so we’ve made a concerted effort to switch our evidence strategy from that of solely glycemic control to one of the hard outcomes. We call the glucose control more of an intermediary outcome and we know that we can reduce hypoglycemia in hospitals. We know that we can reduce hypoglycemia and keep people in that glucose target range more frequently.

Now what we want to do, and what we have done, is proven that improving that intermediate outcome actually improves the harder outcomes. The hard outcomes to me, especially as a clinician, are length of stay so my patients can go home sooner from the hospital, readmissions so my patients don’t have to come back in the hospital, obviously both of those are advantageous, but we can also reduce infection rates etc. So, that’s what we have targeting here over the last little bit, making sure that glucose control translates into those harder outcomes and the financial outcomes that they reward as well.

Related Videos
Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC
Nini Wu, MD, Navista
Matthew Viggiano, MD, internal medicine resident, Temple University Hospital
Krunal Patel, MD, pulmonary and critical care fellow, Temple University Hospital
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Tom Belmon, CAP, GPBCH
Tom Belmont
 Sandeep Sahay, MD, FCCP, director of the Pulmonary Hypertension Program, Houston Methodist Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo